VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gladius Capital Management LP | 10,009 | $21,220 | 0.00% |
| FMR LLC | 7,651,176 | $16,220,493 | 0.00% |
| GRIMES & COMPANY, INC. | 13,986 | $29,650 | 0.00% |
| STATE STREET CORP | 605,907 | $1,284,523 | 0.00% |
| SG Americas Securities, LLC | 17,258 | $37 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 21,616 | $46 | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 45 | $95 | 0.00% |
| CITIGROUP INC | 18 | $38 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 103,918 | $220,306 | 0.00% |
| GOLDMAN SACHS GROUP INC | 25,562 | $54,191 | 0.00% |
| MORGAN STANLEY | 77,024 | $163,291 | 0.00% |
| Invesco Ltd. | 14,523 | $30,788 | 0.00% |
| AMALGAMATED BANK | 3,664 | $8 | 0.00% |
| BlackRock Inc. | 2,106,869 | $4,466,562 | 0.00% |
| Bank of New York Mellon Corp | 108,209 | $229,403 | 0.00% |
| Nuveen Asset Management, LLC | 71,504 | $151,588 | 0.00% |
| Citadel Advisors | 3,400 | $7,208 | 0.00% |
| Citadel Advisors | 1,610 | $3,413 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 52,841 | $112,023 | 0.00% |
| Citadel Advisors | 6,200 | $13,144 | 0.00% |
External links
This page lists VOR BIOPHARMA INC's shareholders in Q3 2023. To view VOR BIOPHARMA INC's shareholder history, click here.